Skip to main content
Livermore
Livermore
ZHEN

Vistagen Therapeutics, Inc.

VTGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001411685

No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Vistagen Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
48
−6 vs. Q4 2024
Shares held
15.9M
+421.2K (+2.7%) vs. Q4 2024
Total value
$39.0M
−$5.83M (−13.0%) vs. Q4 2024
New holders
3
12 more added
Sold out
9
20 more reduced

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VTGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 48 institutions
Q1 2021: 74 institutionsQ2 2021: 101 institutionsQ3 2021: 105 institutionsQ4 2021: 106 institutionsQ1 2022: 116 institutionsQ2 2022: 112 institutionsQ3 2022: 93 institutionsQ4 2022: 86 institutionsQ1 2023: 83 institutionsQ2 2023: 33 institutionsQ3 2023: 34 institutionsQ4 2023: 46 institutionsQ1 2024: 42 institutionsQ2 2024: 43 institutionsQ3 2024: 47 institutionsQ4 2024: 54 institutionsQ1 2025: 48 institutionsQ2 2025: 51 institutionsQ3 2025: 58 institutionsQ4 2025: 55 institutionsQ1 2026: 56 institutionsQ2 2026: 48 institutions
Value heldQ1 2025: $39.0M
Q1 2021: $225.2MQ2 2021: $389.0MQ3 2021: $360.2MQ4 2021: $269.2MQ1 2022: $167.8MQ2 2022: $122.1MQ3 2022: $9.13MQ4 2022: $4.15MQ1 2023: $4.79MQ2 2023: $1.82MQ3 2023: $15.7MQ4 2023: $90.0MQ1 2024: $90.8MQ2 2024: $56.3MQ3 2024: $45.3MQ4 2024: $44.9MQ1 2025: $39.0MQ2 2025: $30.3MQ3 2025: $81.8MQ4 2025: $8.84MQ1 2026: $8.12MQ2 2026: $2.54M
Institutions holding VTGN and their total value by quarter
QuarterHoldersValue
Q2 202648$2.54M
Q1 202656$8.12M
Q4 202555$8.84M
Q3 202558$81.8M
Q2 202551$30.3M
Q1 202548$39.0M
Q4 202454$44.9M
Q3 202447$45.3M
Q2 202443$56.3M
Q1 202442$90.8M
Q4 202346$90.0M
Q3 202334$15.7M
Q2 202333$1.82M
Q1 202383$4.79M
Q4 202286$4.15M
Q3 202293$9.13M
Q2 2022112$122.1M
Q1 2022116$167.8M
Q4 2021106$269.2M
Q3 2021105$360.2M
Q2 2021101$389.0M
Q1 202174$225.2M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Vistagen Therapeutics, Inc.; share changes are against Q4 2024.

Institutions holding VTGN in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
TCG Crossover Management, LLC2,676,580$6.69M0.91%00.0%Unchanged
StemPoint Capital LP2,366,554$5.11M1.63%+38,062+1.6%Added
Nantahala Capital Management, LLC1,978,492$4.95M0.41%−3,488−0.2%Reduced
Vanguard Group Inc1,960,172$4.90M0.00%−60,179−3.0%Reduced
Commodore Capital LP1,575,000$3.94M0.29%00.0%Unchanged
Sphera Funds Management Ltd.790,550$1.98M0.49%−18,000−2.2%Reduced
JPMorgan Chase & Co750,876$1.88M0.00%−21,368−2.8%Reduced
Ikarian Capital, LLC601,703$1.50M0.49%+524,087+675.2%Added
Diadema Partners LP565,975$1.41M1.13%+123,455+27.9%Added
ADAR1 Capital Management, LLC420,765$1.05M0.20%+299,304+246.4%Added
BlackRock, Inc.416,338$1.04M0.00%+4,785+1.2%Added
Geode Capital Management, LLC270,187$675.8K0.00%+13,261+5.2%Added
Almitas Capital LLC254,655$636.6K0.21%00.0%Unchanged
Boothbay Fund Management, LLC177,858$444.6K0.02%+155,443+693.5%Added
BML Capital Management, LLC150,000$375.0K0.30%00.0%Unchanged
AdvisorShares Investments LLC159,114$372.3K0.07%+59,304+59.4%Added
Persistent Asset Partners Ltd121,651$304.1K0.27%00.0%Unchanged
Two Sigma Investments, LP112,507$281.3K0.00%−24,827−18.1%Reduced
Blair William & Co100,866$252.2K0.00%+2,400+2.4%Added
State Street Corp96,858$242.1K0.00%00.0%Unchanged
Susquehanna International Group, LLP64,781$162.0K0.00%−31,125−32.5%Reduced
Morgan Stanley51,285$128.2K0.00%+34,193+200.1%Added
Northern Trust Corp48,093$120.2K0.00%+2,882+6.4%Added
American Century Companies Inc31,063$77.7K0.00%+1,061+3.5%Added
Prosperity Wealth Management, Inc.27,600$69.0K0.03%−1,650−5.6%Reduced
UBS Group AG25,779$64.4K0.00%−106,535−80.5%Reduced
Renaissance Technologies LLC24,800$62.0K0.00%−58,900−70.4%Reduced
Charles Schwab Investment Management Inc23,302$58.3K0.00%00.0%Unchanged
HighTower Advisors, LLC20,828$52.1K0.00%00.0%Unchanged
Kestra Advisory Services, LLC20,033$50.1K0.00%−83−0.4%Reduced
Dimensional Fund Advisors LP17,545$43.9K0.00%+17,545New
Two Sigma Advisers, LP10,732$26.8K0.00%−1,300−10.8%Reduced
Cubist Systematic Strategies, LLC10,088$25.2K0.00%+10,088New
Group One Trading, L.P.5,569$13.9K0.00%−92,158−94.3%Reduced
Advisor Group Holdings, Inc.5,494$13.7K0.00%−5,936−51.9%Reduced
Simplex Trading, LLC2,402$6.00K0.00%−191−7.4%Reduced
CWM, LLC1,582$4.00K0.00%−1,834−53.7%Reduced
Performa Ltd (US), LLC1,000$2.50K0.00%00.0%Unchanged
Royal Bank of Canada911$2.00K0.00%−948−51.0%Reduced
Bank of America Corp677$1.69K0.00%−20,464−96.8%Reduced
MAI Capital Management576$1.44K0.00%−33−5.4%Reduced
BNP Paribas Arbitrage, SA471$1.18K0.00%−2−0.4%Reduced
SBI Securities Co., Ltd.286$7150.00%00.0%Unchanged
SJS Investment Consulting Inc.100$2500.00%00.0%Unchanged
Jones Financial Companies LLLP80$2070.00%−200−71.4%Reduced
Fairman Group, LLC29$860.00%00.0%Unchanged
Citigroup Inc3$80.00%00.0%Unchanged
Barclays PLC1$30.00%+1New
Goldman Sachs Group Inc0$00.00%−194,533−100.0%Sold out
Squarepoint Ops LLC0$00.00%−107,744−100.0%Sold out
Landscape Capital Management, L.L.C.0$00.00%−41,804−100.0%Sold out
Millennium Management LLC0$00.00%−38,732−100.0%Sold out
Man Group plc0$00.00%−18,338−100.0%Sold out
R Squared Ltd0$00.00%−8,610−100.0%Sold out
Caption Management, LLC0$00.00%−4,460−100.0%Sold out
BFSG, LLC0$00.00%−1,000−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−223−100.0%Sold out